Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Oncology Institute Inc - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE
Ticker
Exchange
SIC #
Website
Latest Ticker
TOI
Nasdaq
8011
https://theoncologyinstitute.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Oncology Institute Inc
Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI)
- Nov 16th, 2023 10:04 am
Even With A 49% Surge, Cautious Investors Are Not Rewarding The Oncology Institute, Inc.'s (NASDAQ:TOI) Performance Completely
- Nov 10th, 2023 10:02 am
The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens
- Nov 8th, 2023 10:50 pm
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
- Nov 8th, 2023 9:05 pm
Oncology Institute Decline Means Insider Profits Down To US$113k
- Nov 7th, 2023 3:34 pm
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
- Oct 18th, 2023 12:03 pm
The Oncology Institute Names Jeremy Castle as Chief Operations Officer
- Oct 11th, 2023 8:05 pm
The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit
- Sep 26th, 2023 8:05 pm
The Oncology Institute Regains Compliance with Nasdaq Listing Requirements
- Sep 18th, 2023 12:00 pm
Private equity firms in The Oncology Institute, Inc. (NASDAQ:TOI) are its biggest bettors, and their bets paid off as stock gained 44% last week
- Sep 12th, 2023 10:21 am
Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology
- Aug 9th, 2023 12:10 pm
The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
- Aug 8th, 2023 8:40 pm
Oncology Institute (NASDAQ:TOI) shareholders have endured a 90% loss from investing in the stock three years ago
- Aug 2nd, 2023 10:16 am
The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations
- Jul 31st, 2023 12:00 pm
The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call
- Jul 18th, 2023 12:00 pm
The Oncology Institute Announces Leadership Transition
- Jun 12th, 2023 10:00 am
The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research
- Jun 9th, 2023 12:00 pm
The Oncology Institute to Open Project Southland
- Jun 7th, 2023 12:00 pm
The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting
- May 31st, 2023 12:01 pm
The Oncology Institute to Participate at Upcoming Investor Conferences
- May 31st, 2023 12:00 pm
Scroll